Product Details

Auro-Amoxiclav

Amoxicillin + Clavulanic Acid
250 mg + 125 mg
Tablet


DIN/PIN/NPN

02471671

Manufacturer

Auro Pharma Inc.

Formulary Listing Date

2022-04-29  

Unit Price

0.2467

Amount MOH Pays

0.2467

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.

ATC Code

J01CR02

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
01916866 Clavulin NA NA
02243350 Apo-Amoxi Clav 0.2467 0.2467
02471671 Auro-Amoxiclav 0.2467 0.2467
02508249 Jamp Amoxi Clav 0.2467 0.2467
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph